GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (INGN) (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...
Inogen estimates preliminary, unaudited total revenue of about $82 million for the fourth quarter of ...
Welcome to Inogen’s Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session.
Zacks Investment Research on MSN
Here's why you should add Inogen stock to your portfolio now
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator ...
It has been about a month since the last earnings report for Inogen (INGN). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...
Inogen, Inc. INGN incurred an adjusted loss per share of 57 cents for fourth-quarter 2022, narrower than an adjusted loss per share of 88 cents in the year-ago period. The figure was also narrower ...
Inogen (INGN) came out with a quarterly loss of $1.01 per share versus the Zacks Consensus Estimate of a loss of $0.74. This compares to loss of $0.23 per share a year ago. These figures are adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback